ICH E2F DEVELOPMENT SAFETY UPDATE REPORT

Title:
ICH E2F DEVELOPMENT SAFETY UPDATE REPORT

https://www.gmp-compliance.org/files/guidemgr/E2F_Step_4.pdf

Origin/Publisher:

ICH

Content:
The main focus of the DSUR is data from interventional clinical trials (referred to in this document as "clinical trials") of investigational drugs including biologicals, with or without a marketing approval, whether conducted by commercial or non-commercial sponsors.

Go back